{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:46:27Z","timestamp":1760150787833,"version":"build-2065373602"},"reference-count":105,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wilhelm Sander-Stiftung","award":["2014.162.2, 2014.162.3","80768081","80768076","2021-EKSE.92"],"award-info":[{"award-number":["2014.162.2, 2014.162.3","80768081","80768076","2021-EKSE.92"]}]},{"name":"Robert Pfleger Stiftung","award":["2014.162.2, 2014.162.3","80768081","80768076","2021-EKSE.92"],"award-info":[{"award-number":["2014.162.2, 2014.162.3","80768081","80768076","2021-EKSE.92"]}]},{"name":"Stiftung Transfusionsmedizin und Immunh\u00e4matologie","award":["2014.162.2, 2014.162.3","80768081","80768076","2021-EKSE.92"],"award-info":[{"award-number":["2014.162.2, 2014.162.3","80768081","80768076","2021-EKSE.92"]}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2014.162.2, 2014.162.3","80768081","80768076","2021-EKSE.92"],"award-info":[{"award-number":["2014.162.2, 2014.162.3","80768081","80768076","2021-EKSE.92"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Hemato-oncological diseases account for nearly 10% of all malignancies and can be classified into leukemia, lymphoma, myeloproliferative diseases, and myelodysplastic syndromes. The causes and prognosis of these disease entities are highly variable. Most entities are not permanently controllable and ultimately lead to the patient\u2019s death. At the molecular level, recurrent mutations including chromosomal translocations initiate the transformation from normal stem-\/progenitor cells into malignant blasts finally floating the patient\u2019s bone marrow and blood system. In acute myeloid leukemia (AML), the so-called master transcription factors such as RUNX1, KMT2A, and HOX are frequently disrupted by chromosomal translocations, resulting in neomorphic oncogenic fusion genes. Triggering ex vivo expansion of primary human CD34+ stem\/progenitor cells represents a distinct characteristic of such chimeric AML transcription factors. Regarding oncogenic mechanisms of AML, most studies focus on murine models. However, due to biological differences between mice and humans, findings are only partly transferable. This review focuses on the genetic manipulation of human CD34+ primary hematopoietic stem\/progenitor cells derived from healthy donors to model acute myeloid leukemia cell growth. Analysis of defined single- or multi-hit human cellular AML models will elucidate molecular mechanisms of the development, maintenance, and potential molecular intervention strategies to counteract malignant human AML blast cell growth.<\/jats:p>","DOI":"10.3390\/cells13010078","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T09:15:11Z","timestamp":1703841311000},"page":"78","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Deciphering Acute Myeloid Leukemia Associated Transcription Factors in Human Primary CD34+ Hematopoietic Stem\/Progenitor Cells"],"prefix":"10.3390","volume":"13","author":[{"given":"Sophie","family":"Kreissig","sequence":"first","affiliation":[{"name":"Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, LMU University Hospital, LMU Munich, 81377 Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Windisch","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, LMU University Hospital, LMU Munich, 81377 Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Wichmann","sequence":"additional","affiliation":[{"name":"Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology, LMU University Hospital, LMU Munich, 81377 Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,12,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3389\/fgene.2015.00290","article-title":"Normal vs. Malignant hematopoiesis: The complexity of acute leukemia through systems biology","volume":"6","author":"Enciso","year":"2015","journal-title":"Front. Genet."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Hou, H.A., and Tien, H.F. (2020). Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies. J. Biomed. Sci., 27.","DOI":"10.1186\/s12929-020-00674-7"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.genom.3.032802.115046","article-title":"Genetics of myeloid leukemias","volume":"3","author":"Kelly","year":"2002","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/ng.2651","article-title":"A panoramic view of acute myeloid leukemia","volume":"45","author":"Chen","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"106727","DOI":"10.1016\/j.leukres.2021.106727","article-title":"A concise review on the molecular genetics of acute myeloid leukemia","volume":"111","author":"Padmakumar","year":"2021","journal-title":"Leuk. Res."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research Network, Ley, T.J., Miller, C., Ding, L., Raphael, B.J., Mungall, A.J., Robertson, A., Hoadley, K., Triche, T.J., and Laird, P.W. (2013). Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med., 368, 2059\u20132074.","DOI":"10.1056\/NEJMoa1301689"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: Integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/s41375-023-01909-w","article-title":"AML classification in the year 2023: How to avoid a Babylonian confusion of languages","volume":"37","author":"Huber","year":"2023","journal-title":"Leukemia"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1182\/blood-2003-05-1762","article-title":"Maintaining the self-renewal and differentiation potential of human CD34+ hematopoietic cells using a single genetic element","volume":"102","author":"Mulloy","year":"2003","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/blood.V99.1.15","article-title":"The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells","volume":"99","author":"Mulloy","year":"2002","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1182\/blood-2005-12-012773","article-title":"Human CD34+ cells expressing the inv(16) fusion protein exhibit a myelomonocytic phenotype with greatly enhanced proliferative ability","volume":"108","author":"Wunderlich","year":"2006","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1182\/blood-2010-12-322230","article-title":"Enforced expression of MLL-AF4 fusion in cord blood CD34+ cells enhances the hematopoietic repopulating cell function and clonogenic potential but is not sufficient to initiate leukemia","volume":"117","author":"Montes","year":"2011","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.1182\/blood-2010-02-270660","article-title":"BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells","volume":"116","author":"Rizo","year":"2010","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ccr.2008.04.020","article-title":"Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia","volume":"13","author":"Wei","year":"2008","journal-title":"Cancer Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"11781","DOI":"10.1158\/0008-5472.CAN-06-0706","article-title":"Enforced expression of NUP98-HOXA9 in human CD34(+) cells enhances stem cell proliferation","volume":"66","author":"Chung","year":"2006","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1182\/bloodadvances.2018024422","article-title":"RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs","volume":"3","author":"Gerritsen","year":"2019","journal-title":"Blood Adv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1126\/science.1139851","article-title":"Modeling the initiation and progression of human acute leukemia in mice","volume":"316","author":"Barabe","year":"2007","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.molmed.2004.08.005","article-title":"MLL: A histone methyltransferase disrupted in leukemia","volume":"10","author":"Hess","year":"2004","journal-title":"Trends Mol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.semcancer.2005.01.007","article-title":"The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis","volume":"15","author":"Daser","year":"2005","journal-title":"Semin. Cancer Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1182\/blood-2012-03-362608","article-title":"Diagnosis and management of acute myeloid leukemia in children and adolescents: Recommendations from an international expert panel","volume":"120","author":"Creutzig","year":"2012","journal-title":"Blood"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/378505a0","article-title":"Altered Hox expression and segmental identity in Mll-mutant mice","volume":"378","author":"Yu","year":"1995","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"10632","DOI":"10.1073\/pnas.95.18.10632","article-title":"MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis","volume":"95","author":"Yu","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.cub.2004.11.012","article-title":"An Mll-dependent Hox program drives hematopoietic progenitor expansion","volume":"14","author":"Ernst","year":"2004","journal-title":"Curr. Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"12000","DOI":"10.1073\/pnas.1301278110","article-title":"An MLL-dependent network sustains hematopoiesis","volume":"110","author":"Artinger","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1097-2765(02)00740-2","article-title":"ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation","volume":"10","author":"Nakamura","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1097-2765(02)00741-4","article-title":"MLL targets SET domain methyltransferase activity to Hox gene promoters","volume":"10","author":"Milne","year":"2002","journal-title":"Mol. Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/s41375-023-01877-1","article-title":"The KMT2A recombinome of acute leukemias in 2023","volume":"37","author":"Meyer","year":"2023","journal-title":"Leukemia"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0092-8674(00)81269-6","article-title":"An Mll-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: A method to create fusion oncogenes","volume":"85","author":"Corral","year":"1996","journal-title":"Cell"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fonc.2017.00022","article-title":"Overview of the Use of Murine Models in Leukemia and Lymphoma Research","volume":"7","author":"Kohnken","year":"2017","journal-title":"Front. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.stem.2012.01.006","article-title":"Hematopoiesis: A human perspective","volume":"10","author":"Doulatov","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood-2002-06-1694","article-title":"Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD\/SCID mice express flt3: Distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells","volume":"102","author":"Sitnicka","year":"2003","journal-title":"Blood"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: Differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/hmg\/ddl444","article-title":"The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling","volume":"16","author":"Bitoun","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ccr.2009.12.040","article-title":"A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription","volume":"17","author":"Yokoyama","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.molcel.2006.06.014","article-title":"Controlling the elongation phase of transcription with P-TEFb","volume":"23","author":"Peterlin","year":"2006","journal-title":"Mol. Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1146\/annurev-biochem-060713-035418","article-title":"Genome engineering with targetable nucleases","volume":"83","author":"Carroll","year":"2014","journal-title":"Annu. Rev. Biochem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"618378","DOI":"10.3389\/fgeed.2021.618378","article-title":"Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles toward Clinical Translation","volume":"3","author":"Ferrari","year":"2021","journal-title":"Front. Genome Ed."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/nbt.3659","article-title":"Applications of CRISPR technologies in research and beyond","volume":"34","author":"Barrangou","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.1038\/s41467-021-27270-z","article-title":"A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program","volume":"12","author":"Rice","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Marschalek, R. (2020). The reciprocal world of MLL fusions: A personal view. Biochim. Biophys. Acta Gene Regul. Mech., 1863.","DOI":"10.1016\/j.bbagrm.2020.194547"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1038\/s41388-021-02001-2","article-title":"The role of reciprocal fusions in MLL-r acute leukemia: Studying the chromosomal translocation t(4;11)","volume":"40","author":"Wilhelm","year":"2021","journal-title":"Oncogene"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"7313","DOI":"10.1128\/MCB.22.20.7313-7324.2002","article-title":"Mouse Af9 is a controller of embryo patterning, like Mll, whose human homologue fuses with Af9 after chromosomal translocation in leukemia","volume":"22","author":"Collins","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41586-019-1790-2","article-title":"MLLT3 governs human haematopoietic stem-cell self-renewal and engraftment","volume":"576","author":"Calvanese","year":"2019","journal-title":"Nature"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1182\/bloodadvances.2017013748","article-title":"MLL leukemia induction by t(9;11) chromosomal translocation in human hematopoietic stem cells using genome editing","volume":"2","author":"Schneidawind","year":"2018","journal-title":"Blood Adv."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1007\/s00018-018-2895-8","article-title":"ENL: Structure, function, and roles in hematopoiesis and acute myeloid leukemia","volume":"75","author":"Zhou","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood-2007-05-090514","article-title":"A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification","volume":"110","author":"Mueller","year":"2007","journal-title":"Blood"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1007579","DOI":"10.3389\/fimmu.2022.1007579","article-title":"The development and improvement of immunodeficient mice and humanized immune system mouse models","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/ajh.23266","article-title":"Lineage switch in childhood acute leukemia: An unusual event with poor outcome","volume":"87","author":"Rossi","year":"2012","journal-title":"Am. J. Hematol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-0716-2788-4_3","article-title":"Defined Human Leukemic CD34+ Liquid Cultures to Study HDAC\/Transcriptional Repressor Complexes","volume":"2589","author":"Windisch","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1182\/blood-2015-05-646398","article-title":"MLL leukemia induction by genome editing of human CD34+ hematopoietic cells","volume":"126","author":"Buechele","year":"2015","journal-title":"Blood"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.3324\/haematol.2017.164046","article-title":"CRISPR-Cas9-induced t(11;19)\/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo","volume":"102","author":"Reimer","year":"2017","journal-title":"Haematologica"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1038\/sj.onc.1207763","article-title":"Core-binding factors in hematopoiesis and immune function","volume":"23","author":"Speck","year":"2004","journal-title":"Oncogene"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"10431","DOI":"10.1073\/pnas.88.23.10431","article-title":"t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1","volume":"88","author":"Miyoshi","year":"1991","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.2741\/3977","article-title":"RUNX1 and RUNX1-ETO: Roles in hematopoiesis and leukemogenesis","volume":"17","author":"Lam","year":"2012","journal-title":"Front. Biosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/978-981-10-3233-2_11","article-title":"RUNX1-ETO Leukemia","volume":"962","author":"Lin","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"10860","DOI":"10.1073\/pnas.95.18.10860","article-title":"ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR\/mSin3\/HDAC1 complex","volume":"95","author":"Wang","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1126\/science.1201662","article-title":"The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation","volume":"333","author":"Wang","year":"2011","journal-title":"Science"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/febs.14751","article-title":"The RUNX1-ETO fusion protein trans-activates c-KIT expression by recruiting histone acetyltransferase P300 on its promoter","volume":"286","author":"Chen","year":"2019","journal-title":"FEBS J."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41388-018-0441-7","article-title":"Compatibility of RUNX1\/ETO fusion protein modules driving CD34+ human progenitor cell expansion","volume":"38","author":"Shvartsman","year":"2019","journal-title":"Oncogene"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nm1443","article-title":"A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis","volume":"12","author":"Yan","year":"2006","journal-title":"Nat. Med."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"9075","DOI":"10.1073\/pnas.1524225113","article-title":"Supraphysiologic levels of the AML1-ETO isoform AE9a are essential for transformation","volume":"113","author":"Link","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1182\/blood-2012-11-465641","article-title":"Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential","volume":"121","author":"DeKelver","year":"2013","journal-title":"Blood"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0092-8674(00)81388-4","article-title":"Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11","volume":"87","author":"Castilla","year":"1996","journal-title":"Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1182\/blood-2011-07-328880","article-title":"NUP98 gene fusions and hematopoietic malignancies: Common themes and new biologic insights","volume":"118","author":"Gough","year":"2011","journal-title":"Blood"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1074\/jbc.M307280200","article-title":"The oncogene Nup98-HOXA9 induces gene transcription in myeloid cells","volume":"279","author":"Ghannam","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.1158\/0008-5472.CAN-06-0458","article-title":"NUP98-HOXA9 induces long-term proliferation and blocks differentiation of primary human CD34+ hematopoietic cells","volume":"66","author":"Takeda","year":"2006","journal-title":"Cancer Res."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Abraham, A., Kim, Y.S., Zhao, H., Humphries, K., and Persons, D.A. (2016). Increased Engraftment of Human Short Term Repopulating Hematopoietic Cells in NOD\/SCID\/IL2rgammanull Mice by Lentiviral Expression of NUP98-HOXA10HD. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0147059"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Zhang, X., Sun, J., Yu, W., and Jin, J. (2021). Current views on the genetic landscape and management of variant acute promyelocytic leukemia. Biomark. Res., 9.","DOI":"10.1186\/s40364-021-00284-x"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.bbadis.2010.10.007","article-title":"The molecular physiology of nuclear retinoic acid receptors. From health to disease","volume":"1812","author":"Duong","year":"2011","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Lavudi, K., Nuguri, S.M., Olverson, Z., Dhanabalan, A.K., Patnaik, S., and Kokkanti, R.R. (2023). Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1254612"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nrd2397","article-title":"RAR and RXR modulation in cancer and metabolic disease","volume":"6","author":"Altucci","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Guan, D., and Kao, H.Y. (2015). The function, regulation and therapeutic implications of the tumor suppressor protein, PML. Cell Biosci., 5.","DOI":"10.1186\/s13578-015-0051-9"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Noguera, N.I., Catalano, G., Banella, C., Divona, M., Faraoni, I., Ottone, T., Arcese, W., and Voso, M.T. (2019). Acute Promyelocytic Leukemia: Update on the Mechanisms of Leukemogenesis, Resistance and on Innovative Treatment Strategies. Cancers, 11.","DOI":"10.20944\/preprints201910.0159.v1"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000496097","article-title":"Morphological and Immunophenotypic Clues to the WHO Categories of Acute Myeloid Leukaemia","volume":"141","author":"Bain","year":"2019","journal-title":"Acta Haematol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1182\/blood.V85.8.2154.bloodjournal8582154","article-title":"Highly purified primitive hematopoietic stem cells are PML-RARA negative and generate nonclonal progenitors in acute promyelocytic leukemia","volume":"85","author":"Turhan","year":"1995","journal-title":"Blood"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1182\/blood.V96.4.1531","article-title":"PML\/RAR alpha fusion protein expression in normal human hematopoietic progenitors dictates myeloid commitment and the promyelocytic phenotype","volume":"96","author":"Grignani","year":"2000","journal-title":"Blood"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Abdul-Nabi, A.M., Yassin, E.R., Varghese, N., Deshmukh, H., and Yaseen, N.R. (2010). In vitro transformation of primary human CD34+ cells by AML fusion oncogenes: Early gene expression profiling reveals possible drug target in AML. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012464"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1182\/blood.V94.2.793","article-title":"Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes","volume":"94","author":"Du","year":"1999","journal-title":"Blood"},{"key":"ref_82","first-page":"53","article-title":"NOD\/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models","volume":"324","author":"Ito","year":"2008","journal-title":"Curr. Top Microbiol. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Matsushita, H., Yahata, T., Sheng, Y., Nakamura, Y., Muguruma, Y., Matsuzawa, H., Tanaka, M., Hayashi, H., Sato, T., and Damdinsuren, A. (2014). Establishment of a humanized APL model via the transplantation of PML-RARA-transduced human common myeloid progenitors into immunodeficient mice. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0111082"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nature01572","article-title":"Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells","volume":"423","author":"Lessard","year":"2003","journal-title":"Nature"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.exphem.2022.02.004","article-title":"Bmi1 induction protects hematopoietic stem cells against pronounced long-term hematopoietic stress","volume":"109","author":"Hidalgo","year":"2022","journal-title":"Exp. Hematol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4137\/BIC.S33376","article-title":"BMI1: A Biomarker of Hematologic Malignancies","volume":"8","author":"Sahasrabuddhe","year":"2016","journal-title":"Biomark. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1182\/blood-2007-08-106666","article-title":"Long-term maintenance of human hematopoietic stem\/progenitor cells by expression of BMI1","volume":"111","author":"Rizo","year":"2008","journal-title":"Blood"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.biocel.2006.12.005","article-title":"c-Kit\u2014A hematopoietic cell essential receptor tyrosine kinase","volume":"39","author":"Edling","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11899-009-0011-8","article-title":"Clinical implications of c-Kit mutations in acute myelogenous leukemia","volume":"4","author":"Malaise","year":"2009","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/leu.2014.179","article-title":"Activating c-KIT mutations confer oncogenic cooperativity and rescue RUNX1\/ETO-induced DNA damage and apoptosis in human primary CD34+ hematopoietic progenitors","volume":"29","author":"Wichmann","year":"2015","journal-title":"Leukemia"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.exphem.2020.10.005","article-title":"RUNX1\/ETO and mutant KIT both contribute to programming the transcriptional and chromatin landscape in t(8;21) acute myeloid leukemia","volume":"92","author":"Chin","year":"2020","journal-title":"Exp. Hematol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1535-6108(02)00016-8","article-title":"Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia","volume":"1","author":"Higuchi","year":"2002","journal-title":"Cancer Cell"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"10398","DOI":"10.1073\/pnas.171321298","article-title":"AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations","volume":"98","author":"Yuan","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1182\/blood.V96.6.2108","article-title":"Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model","volume":"96","author":"Rhoades","year":"2000","journal-title":"Blood"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1182\/blood-2011-02-338228","article-title":"Distinct classes of c-Kit-activating mutations differ in their ability to promote RUNX1-ETO-associated acute myeloid leukemia","volume":"119","author":"Nick","year":"2012","journal-title":"Blood"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1073\/pnas.1019625108","article-title":"C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice","volume":"108","author":"Wang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/leu.2015.275","article-title":"UBASH3B\/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO","volume":"30","author":"Goyama","year":"2016","journal-title":"Leukemia"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/10428190400010767","article-title":"AML1\/ETO promotes the maintenance of early hematopoietic progenitors in NOD\/SCID mice but does not abrogate their lineage specific differentiation","volume":"46","author":"Basecke","year":"2005","journal-title":"Leuk. Lymphoma"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood-2010-01-264119","article-title":"N-Ras(G12D) induces features of stepwise transformation in preleukemic human umbilical cord blood cultures expressing the AML1-ETO fusion gene","volume":"117","author":"Chou","year":"2011","journal-title":"Blood"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/978-3-030-34025-4_23","article-title":"In Vitro and Ex Vivo Models\u2014The Tumor Microenvironment in a Flask","volume":"1219","author":"Pinto","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s40495-016-0050-5","article-title":"Oxidative stress under ambient and physiological oxygen tension in tissue culture","volume":"2","author":"Jagannathan","year":"2016","journal-title":"Curr. Pharmacol. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2051-1426-1-13","article-title":"Immune evasion in acute myeloid leukemia: Current concepts and future directions","volume":"1","author":"Teague","year":"2013","journal-title":"J. Immunother. Cancer"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fonc.2018.00213","article-title":"Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity","volume":"8","author":"Lamble","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.critrevonc.2016.04.020","article-title":"Harnessing the immune system in acute myeloid leukaemia","volume":"103","author":"Austin","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.trecan.2020.08.007","article-title":"Mice Are Not Humans: The Case of p53","volume":"7","author":"Fischer","year":"2021","journal-title":"Trends Cancer"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/1\/78\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:44:18Z","timestamp":1760132658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/1\/78"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,29]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["cells13010078"],"URL":"https:\/\/doi.org\/10.3390\/cells13010078","relation":{},"ISSN":["2073-4409"],"issn-type":[{"type":"electronic","value":"2073-4409"}],"subject":[],"published":{"date-parts":[[2023,12,29]]}}}